Divalproex Sodium
Product Images NDC 68788-8085
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68788-8085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)
The text appears to be a graph or chart showing the percentage reduction in the CPS rate for patients taking Divalproex Sodium Delayed-Release compared to a placebo. It shows a 50% improvement in patients taking the drug compared to those taking the placebo. There is also a section indicating whether there was no change or worsening in the CPS rate.*
Image 3 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)
Image 4 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)
Divalproex Sodium Er Tab 500mg (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 06)
This is a description for Divalproex Sodium ER Tab 500mg, which is a generic for Depakote ER manufactured by Lupin Pharmaceuticals. The tablet is oval shaped and imprinted with L039. Each tablet contains valproic acid 500mg. The package size, expiration date, lot number, batch number, and manufacturer details are also provided. The directions are not available, and it is cautioned that federal law prohibits the transfer of this drug to anyone other than the patient for whom it was prescribed. There are also some additional details about the product quantity, insurance NDC, lot number, batch number, and product NDC available in a log chart.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.